4.2 Review

Behavioral medicine for migraine and medication overuse headache

Journal

CURRENT PAIN AND HEADACHE REPORTS
Volume 13, Issue 3, Pages 241-248

Publisher

SPRINGER
DOI: 10.1007/s11916-009-0041-x

Keywords

-

Funding

  1. National Headache Foundation from Allergan Pharmaceuticals
  2. GlaxoSmithKline
  3. Merck
  4. Ortho-McNeil Neurologics Inc.
  5. Endo Pharmaceuticals

Ask authors/readers for more resources

Primary headaches, including migraine and medication overuse headache (MOH), can be conceptualized as biobehavioral disorders based on the interaction of biological, psychological, and environmental factors. This article reviews empirically supported and efficacious behavioral approaches to the treatment and management of headaches in general, with an emphasis on migraine and MOH from a biopsychosocial perspective. Evidence-based behavioral medicine treatments for migraine and MOH are reviewed, including patient education, cognitive behavioral therapy, and biobehavioral training (biofeedback, relaxation training, and stress management). Information regarding psychological comorbidities and risk factors for progression of migraine and the development of MOH is also reviewed. Strategies are provided for enhancing adherence and motivation, as well as facilitating medical communication.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available